Discontinuation report PRADAXA
Report ID | 26385 |
Drug Identification Number | 02358808 |
Brand name | PRADAXA |
Common or Proper name | Pradaxa Bottles 60's |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | DABIGATRAN ETEXILATE |
Strength(s) | 150MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | Bottle of 60's |
ATC code | B01AE |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-10-18 |
Remaining supply date | 2017-10-18 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Pradaxa 150mg 6x10 Blister Pack format remains available |
Company comments | Pradaxa 150mg 6x10 Blister Pack format remains available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-10-19 | English | Compare |
v2 | 2017-10-19 | French | Compare |
v3 | 2017-10-19 | English | Compare |
v4 | 2017-10-19 | French | Compare |
Showing 1 to 4 of 4